Budget impact and cost-utility analysis of prophylactic emicizumab versus on-demand bypassing agents for adolescent severe haemophilia A patients with inhibitors in India
| Autor: | Krishnamoorthy, Yuvaraj, Govindan, Dhanajayan, Kannan, Narasimhapriyan, Majella, Marie Gilbert, Hariharan, Vishnu Shankar, Valliappan, Vivek |
|---|---|
| Zdroj: | In Heliyon 15 March 2024 10(5) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|